Article
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
30 Mar 2020
Abstract excerpt
BACKGROUND & AIMS: Hepatoblastoma (HB) is a rare disease. Nevertheless, it is the predominant pediatric liver cancer, with limited therapeutic options for patients with aggressive tumors. Herein, we aimed to uncover the mechanisms of HB pathobiology and to identify new biomarkers and therapeutic targets in a move towards precision medicine for patients with advanced HB. METHODS: We performed a comprehensive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
